DNA Vector pPRA-PSM Vaccine

A cancer vaccine consisting of a DNA plasmid encoding epitopes of the human preferential antigen of melanoma (PRAME) and the prostate specific membrane antigen (PSMA) with potential immunostimulating activity. Upon direct administration of this vaccine into lymph nodes, peptides expressed by DNA plasmid vector pPRA-PSM may activate the immune system, resulting in a cytotoxic T-lymphocyte (CTL) response against PRAME- and PSMA-expressing cells. PRAME and PSMA are tumor associated antigens upregulated in a number of cancer cell types. As part of the MKC1106-PP regimen exploiting the 'prime-boost strategy', this plasmid is responsible for priming the immune response and is used in conjunction with a peptide vaccine consisting of PRAME and PSMA that boosts the immune system against PRAME- and PSMA-expressing tumor cells. (NCI Thesaurus)

YOU MAY ALSO LIKE

DNA Vaccine

DNA vaccines are used in vaccination in way that differs from those are designed to be inserted into germ line of…

DNA Tumor Virus

A virus which uses DNA to code its genome and causes tumors in animals.

DNA Topology Regulation

DNA Topology Regulation involves DNA topoisomerases that catalyze essential DNA transaction processes, including DNA strand scission, manipulation, and rejoining, in order to…

DNA Topoisomerase II Binding Protein

Topoisomerase (DNA) II Binding Protein (TOPBP1), encoded by the TopBP1 gene, is a 173-kD binding protein that interacts with the C-terminal region…

DNA Topoisomerase 3-Beta-1

DNA topoisomerase 3-beta-1 (862 aa, ~97 kDa) is encoded by the human TOP3B gene. This protein plays a role in the modification…

DNA Topoisomerase 3-Alpha

DNA topoisomerase 3-alpha (1001 aa, ~112 kDa) is encoded by the human TOP3A gene. This protein is involved in the relaxation of…